LCH STEERING COMMITTEE
The LCH Steering Committee is responsible for charting strategic direction of the HS in their specified areas, including conduct of clinical trials and engagement with the broader group of investigators interested in LCH.
Michelle Hermiston - Chair
Matthew Collin - Vice-Chair
Seattle Children's Hospital - Seattle, WA USA
Term of Office: 2022 - 2026
The LCH Steering Committee is focused how the Histiocyte Society can facilitate and support collaboration between regional efforts focused on LCH. We appreciate the need for clinical trials to obtain rigorous data and the challenges of doing this with the lack of funds to support coordinate clinical trial infrastructure and regulatory challenges at an international level. We believe that the HS LCH committee can serve an important harmonizing role amongst different regional groups. We are currently focused on two key activities:
Key questions in our field: